Pfizer/BioNTech likely to be effective against new mutant COVID-19 variants - The study by Pfizer and scientists from the University of Texas Medical Branch indicated the vaccine was effective in neutralizing virus
Tsunami of misinformation contributed to drop in vaccine willingness
Willingness around the vaccine was relatively high in April and May but since discussion around vaccines had increased, that had ebbed away
The video will auto-play soon8Cancel
Play now
There are always big stories on WalesOnline - don t miss any with our daily emailInvalid EmailSomething went wrong, please try again later.
Sign me up now
When you subscribe we will use the information you provide to send you these newsletters. Sometimes they’ll include recommendations for other related newsletters or services we offer. OurPrivacy Noticeexplains more about how we use your data, and your rights. You can unsubscribe at any time.
Bart H. Meijer
5 分钟阅读
AMSTERDAM, Jan 6 (Reuters) - EU countries could begin rolling out Moderna’s COVID-19 vaccine as soon as next week after authorities approved the region’s second shot on Wednesday, with more infectious variants of the virus adding extra urgency to inoculation efforts.
Vaccinating the European Union’s 450 million people could be crucial to ending a pandemic that has killed almost 1.9 million people globally. Countries are scrambling to contain two variants found in South Africa and Britain that are more transmissible and have driven a surge in infections.
“With the Moderna vaccine, the second one now authorised in the EU, we will have a further 160 million doses. And more vaccines will come,” European Commission President Ursula von der Leyen said on Wednesday.
Research Article
Associations between breast cancer survivorship and adverse mental health outcomes: A matched population-based cohort study in the United Kingdom
Helena Carreira , Roles Conceptualization, Funding acquisition, Methodology, Supervision, Writing – review & editing
Affiliation Clinical Practice Research Datalink (CPRD), Medicines and Healthcare products Regulatory Agency, London, United Kingdom ⨯
Garth Funston,
Affiliation Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
Affiliation Department of Medicine, The Royal Marsden NHS Foundation Trust, London and Surrey, United Kingdom Roles Conceptualization, Formal analysis, Funding acquisition, Methodology, Supervision, Validation, Writing – review & editing
Affiliation Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London,